Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000745
Filing Date
2025-01-06
Accepted
2025-01-06 16:15:12
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01062025_040106.html 4  
1 form4-01062025_040106.xml 4 4171
  Complete submission text file 0001415889-25-000745.txt   5572
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR NEW YORK NY 10036
Business Address
Romano Steven J. (Reporting) CIK: 0001639860 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 25511272